A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Exact Sciences Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 64,600 shares of EXAS stock, worth $3.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,600
Previous 510,704 87.35%
Holding current value
$3.75 Million
Previous $21.6 Million 79.62%
% of portfolio
0.01%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.43 - $70.83 $18.9 Million - $31.6 Million
-446,104 Reduced 87.35%
64,600 $4.4 Million
Q2 2024

Aug 09, 2024

SELL
$41.33 - $74.26 $19.7 Million - $35.4 Million
-477,200 Reduced 48.3%
510,704 $21.6 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $2.08 Million - $2.73 Million
37,000 Added 3.89%
987,904 $68.2 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $19.9 Million - $25.5 Million
-336,881 Reduced 26.16%
950,904 $70.3 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $44.7 Million - $67.2 Million
678,485 Added 111.35%
1,287,785 $87.9 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $17.9 Million - $27.1 Million
285,200 Added 88.0%
609,300 $57.2 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $10.4 Million - $15.6 Million
220,800 Added 213.75%
324,100 $22 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $1.28 Million - $2.24 Million
42,100 Added 68.79%
103,300 $5.11 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.96 Million - $3.02 Million
61,200 New
61,200 $1.99 Million
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $7.76 Million - $11.5 Million
-82,904 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $61.5 Million - $81.7 Million
-527,300 Reduced 86.41%
82,904 $10.9 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $46.6 Million - $66.5 Million
467,874 Added 328.72%
610,204 $80.8 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $10.4 Million - $14.5 Million
142,330 New
142,330 $14.5 Million
Q4 2019

Feb 13, 2020

SELL
$77.66 - $99.74 $40.4 Million - $51.8 Million
-519,800 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $11.6 Million - $15.7 Million
128,240 Added 32.75%
519,800 $47 Million
Q2 2019

Aug 12, 2019

BUY
$89.51 - $118.04 $23.8 Million - $31.3 Million
265,360 Added 210.27%
391,560 $46.2 Million
Q1 2019

May 14, 2019

BUY
$61.98 - $96.5 $7.82 Million - $12.2 Million
126,200 New
126,200 $10.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.